Citius Oncology, Stock Forecast - Accumulation Distribution

CTOR Stock   0.92  0.02  2.13%   
Citius Stock Forecast is based on your current time horizon. Although Citius Oncology,'s naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Citius Oncology,'s systematic risk associated with finding meaningful patterns of Citius Oncology, fundamentals over time.
  
On November 27, 2024 Citius Oncology, had Accumulation Distribution of 9847.43. The accumulation distribution (A/D) indicator shows the degree to which Citius Oncology, is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Citius Oncology, to determine if accumulation or reduction is taking place in the market. This value is adjusted by Citius Oncology, trading volume to give more weight to distributions with higher volume over lower volume.
Check Citius Oncology, VolatilityBacktest Citius Oncology,Trend Details  

Citius Oncology, Trading Date Momentum

On November 29 2024 Citius Oncology, was traded for  0.92  at the closing time. The top price for the day was 1.00  and the lowest listed price was  0.90 . The trading volume for the day was 39.8 K. The trading history from November 29, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.13% . The overall trading delta against the current closing price is 2.13% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Citius Oncology, to competition

Other Forecasting Options for Citius Oncology,

For every potential investor in Citius, whether a beginner or expert, Citius Oncology,'s price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Citius Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Citius. Basic forecasting techniques help filter out the noise by identifying Citius Oncology,'s price trends.

Citius Oncology, Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Citius Oncology, stock to make a market-neutral strategy. Peer analysis of Citius Oncology, could also be used in its relative valuation, which is a method of valuing Citius Oncology, by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Citius Oncology, Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Citius Oncology,'s price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Citius Oncology,'s current price.

Citius Oncology, Market Strength Events

Market strength indicators help investors to evaluate how Citius Oncology, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Citius Oncology, shares will generate the highest return on investment. By undertsting and applying Citius Oncology, stock market strength indicators, traders can identify Citius Oncology, entry and exit signals to maximize returns.

Citius Oncology, Risk Indicators

The analysis of Citius Oncology,'s basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Citius Oncology,'s investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting citius stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Citius Oncology,

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Citius Oncology, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Oncology, will appreciate offsetting losses from the drop in the long position's value.

Moving together with Citius Stock

  0.66ME 23Andme Holding Upward RallyPairCorr
  0.8VALN Valneva SE ADRPairCorr

Moving against Citius Stock

  0.64VCYT VeracytePairCorr
  0.59DRUG Bright Minds Biosciences TrendingPairCorr
  0.55DMAC DiaMedica Therapeutics TrendingPairCorr
  0.51VERA Vera TherapeuticsPairCorr
The ability to find closely correlated positions to Citius Oncology, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Citius Oncology, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Citius Oncology, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Citius Oncology, to buy it.
The correlation of Citius Oncology, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Citius Oncology, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Citius Oncology, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Citius Oncology, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Citius Stock Analysis

When running Citius Oncology,'s price analysis, check to measure Citius Oncology,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Citius Oncology, is operating at the current time. Most of Citius Oncology,'s value examination focuses on studying past and present price action to predict the probability of Citius Oncology,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Citius Oncology,'s price. Additionally, you may evaluate how the addition of Citius Oncology, to your portfolios can decrease your overall portfolio volatility.